Tammela TL - Search Results

1

Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer.

Buzzoni C, Auvinen A, Roobol MJ, Carlsson S, Moss SM, Puliti D, de Koning HJ, Bangma CH, Denis LJ, Kwiatkowski M, Lujan M, Nelen V, Paez A, Randazzo M, Rebillard X, Tammela TL, Villers A, Hugosson J, Schröder FH, Zappa M. Buzzoni C, et al. Among authors: tammela tl. Eur Urol. 2015 Nov;68(5):885-90. doi: 10.1016/j.eururo.2015.02.042. Epub 2015 Mar 16. Eur Urol. 2015. PMID: 25791513 Free PMC article. Clinical Trial.

2

Sequentially alternating hormone chemotherapy with high-dose medroxy-progesterone acetate and low-dose epirubicin for the treatment of hormone-resistant metastatic prostatic cancer.

Kontturi M, Sotarauta M, Tammela T, Lukkarinen O, Romppainen ML, Gröhn P. Kontturi M, et al. Eur Urol. 1988;15(1-2):43-7. doi: 10.1159/000473393. Eur Urol. 1988. PMID: 2975221

3

Aetiology of priapism in 207 patients.

Kulmala R, Lehtonen T, Nieminen P, Tammela T. Kulmala R, et al. Eur Urol. 1995;28(3):241-5. doi: 10.1159/000475058. Eur Urol. 1995. PMID: 8536779

4

Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland.

Auvinen A, Tammela T, Stenman UH, Uusi-Erkkilä I, Leinonen J, Schröder FH, Hakama M. Auvinen A, et al. Br J Cancer. 1996 Aug;74(4):568-72. doi: 10.1038/bjc.1996.402. Br J Cancer. 1996. PMID: 8761371 Free PMC article. Clinical Trial.

5

Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy with the nonsteroidal potent antiandrogen Casodex (bicalutamide) with a subsequent favorable response to maximal androgen blockade.

Palmberg C, Koivisto P, Hyytinen E, Isola J, Visakorpi T, Kallioniemi OP, Tammela T. Palmberg C, et al. Eur Urol. 1997;31(2):216-9. doi: 10.1159/000474453. Eur Urol. 1997. PMID: 9076469

6

Association of smoking with lower urinary tract symptoms.

Koskimäki J, Hakama M, Huhtala H, Tammela TL. Koskimäki J, et al. Among authors: tammela tl. J Urol. 1998 May;159(5):1580-2. doi: 10.1097/00005392-199805000-00046. J Urol. 1998. PMID: 9554358

7

A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer.

Tyrrell CJ, Kaisary AV, Iversen P, Anderson JB, Baert L, Tammela T, Chamberlain M, Webster A, Blackledge G. Tyrrell CJ, et al. Eur Urol. 1998;33(5):447-56. doi: 10.1159/000019634. Eur Urol. 1998. PMID: 9643663 Clinical Trial.

8

European randomized study of prostate cancer screening: first-year results of the Finnish trial.

Määttänen L, Auvinen A, Stenman UH, Rannikko S, Tammela T, Aro J, Juusela H, Hakama M. Määttänen L, et al. Br J Cancer. 1999 Mar;79(7-8):1210-4. doi: 10.1038/sj.bjc.6690194. Br J Cancer. 1999. PMID: 10098761 Free PMC article. Clinical Trial.

9

Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families.

Matikainen MP, Schleutker J, Mörsky P, Kallioniemi OP, Tammela TL. Matikainen MP, et al. Among authors: tammela tl. Clin Cancer Res. 1999 Jun;5(6):1275-9. Clin Cancer Res. 1999. PMID: 10389909

10

PSA decline is an independent prognostic marker in hormonally treated prostate cancer.

Palmberg C, Koivisto P, Visakorpi T, Tammela TL. Palmberg C, et al. Among authors: tammela tl. Eur Urol. 1999 Sep;36(3):191-6. doi: 10.1159/000067996. Eur Urol. 1999. PMID: 10450001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

607 results

Search Page

Filters